Thrive Capital Management (Pennsylvania)’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
RP
Thrive Capital Management (Pennsylvania)'s ACLS Position: Q3 2024 in Review
Thrive Capital Management (Pennsylvania) sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 5,132 shares — an estimated $730K sold.
Thrive Capital Management (Pennsylvania) first reported a position in ACLS in Q2 2024 and held it in 1 quarter. The position peaked at $730K in Q2 2024. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.
- Thrive Capital Management (Pennsylvania) reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
- Thrive Capital Management (Pennsylvania) sold 5,132 Axcelis shares in Q3 2024, an estimated $730K.
- Thrive Capital Management (Pennsylvania) first reported a position in Axcelis in Q2 2024 and held it in 1 quarter.
- Thrive Capital Management (Pennsylvania)'s Axcelis position peaked at $730K in Q2 2024.
- 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q3 2024, filed 13 Nov 2024.